GIM
RGEN icon

Glenmede Investment Management’s Repligen RGEN Stock Holding History

Glenmede Investment Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.09M Buy
8,133
+820
+11% +$99.6K 0.01% 682
2025
Q2 		$910K Buy
+7,313
New +$931K ﹤0.01% 741

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Glenmede Investment Management's RGEN Position: Q3 2025 in Review

Glenmede Investment Management increased its Repligen (RGEN) stake by 11% in Q3 2025, buying an estimated $99.6K and bringing the position to 8,133 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #682.

Glenmede Investment Management first reported a position in RGEN in Q2 2025 and has held it in 2 quarters since. 451 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Glenmede Investment Management held 8,133 shares of Repligen worth $1.09M as of Q3 2025.
  • Glenmede Investment Management bought 820 Repligen shares in Q3 2025, an estimated $99.6K.
  • Repligen made up 0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #682 holding.
  • Glenmede Investment Management first reported a position in Repligen in Q2 2025 and has held it in 2 quarters since.
  • 451 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.